Evogene Ltd. (EVGN) Institutional Ownership

Ownership Summary

A total of 18 institutions have reported a stake in Evogene Ltd. (NASDAQ:EVGN) as of December 2025, according to recent 13F filings with the SEC.

• The collective stake of institutional investors in Evogene moved to 2.1% in December 2025, a shift up from the 1.8% reported for September 2025.
• On a quarter-over-quarter basis, institutional holdings shifted by 27.13%, with a year-over-year no change in the count of filers.
• Among the 18 institutional holders of Evogene, 5 added to their stakes while 7 trimmed their positions and 6 held steady.
• Collectively, institutional investors increased their stake in Evogene to 181.66K shares as of December 2025, a change that is up by 38.77K shares quarter on quarter and down 220.28K shares year over year.
• With 88.76K shares, CITADEL ADVISORS LLC commands the largest institutional position in Evogene as of December 31, 2025, equating to 1.01% of the company.
• Among the most significant buyers of Evogene during December 2025 were CITADEL ADVISORS LLC (31.19K), XTX Topco Ltd (22.68K), Daytona Street Capital LLC (9.59K), Russell Investments Group, Ltd. (1), Farther Finance Advisors, LLC (1).
• Leading sellers of Evogene stock in December 2025 included MORGAN STANLEY (21.29K), JANE STREET GROUP, LLC (1.48K), BNP PARIBAS FINANCIAL MARKETS (1.11K), SBI Securities Co., Ltd. (597), Tradewinds Capital Management, LLC (169).
• The top 10 institutional holders of Evogene for the quarter ending December 2025 included CITADEL ADVISORS LLC (88.76K), JANE STREET GROUP, LLC (37.94K), XTX Topco Ltd (22.68K), BNP PARIBAS FINANCIAL MARKETS (10.12K), Daytona Street Capital LLC (9.59K), MORGAN STANLEY (9.05K), UBS Group AG (1.20K), Altshuler Shaham Ltd (750), Steward Partners Investment Advisory, LLC (505), Federation des caisses Desjardins du Quebec (500).